Eton Pharmaceuticals (ETON) Cost of Revenue (2019 - 2026)
Eton Pharmaceuticals (ETON) posted Cost of Revenue of $8.2 million for Q4 2025, down 43.98% sequentially from $14.6 million in Q3 2025, and up 58.21% YoY from $5.2 million in Q4 2024.
Eton Pharmaceuticals (ETON) Cost of Revenue (2019 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Cost of Revenue for 7 years, with the latest figure at $8.2 million in Q4 2025.
- Quarterly Cost of Revenue rose 58.21% year-over-year to $8.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $37.2 million (up 138.53% YoY) and the FY2025 annual result came in at $37.2 million, up 138.53% from the prior year.
- Cost of Revenue fell to $8.2 million in Q4 2025 per ETON's latest filing, from $14.6 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $14.6 million in Q3 2025 and troughed at $174000.0 in Q2 2021.
- A 5-year average of $3.7 million and a median of $2.7 million in 2022 frame the typical range for Cost of Revenue.
- The widest YoY moves for Cost of Revenue: up 1477.59% in 2022, down 46.6% in 2022.
- Over 5 years, Cost of Revenue stood at $372000.0 in 2021, then surged by 474.73% to $2.1 million in 2022, then soared by 72.26% to $3.7 million in 2023, then soared by 40.4% to $5.2 million in 2024, then surged by 58.21% to $8.2 million in 2025.
- According to Business Quant data, Cost of Revenue over the past three periods registered $8.2 million, $14.6 million, and $7.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | 12.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.18 Mn |
| Jun 30, 2026 | 12.18 Mn |
| Dec 31, 2025 | 8.18 Mn |
| Dec 31, 2025 | 8.18 Mn |
| Sep 30, 2025 | 14.60 Mn |
| Sep 30, 2025 | 14.60 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Mar 31, 2025 | 7.42 Mn |
| Mar 31, 2025 | 7.42 Mn |
| Dec 31, 2024 | 5.17 Mn |
| Dec 31, 2024 | 5.17 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Jun 30, 2024 | 3.45 Mn |
| Jun 30, 2024 | 3.45 Mn |
| Mar 31, 2024 | 2.96 Mn |
| Mar 31, 2024 | 2.96 Mn |
| Dec 31, 2023 | 3.68 Mn |
| Dec 31, 2023 | 3.68 Mn |